Stryker Biotech

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 25.0

Forward Citations = 49

Loading Chart...

8 inventors (with patents filed for the assignee):

Thangavel Kuberasampath (4 out of 67 patents)

Hermann Oppermann (3 out of 88 patents)

David C Rueger (3 out of 83 patents)

4. Engin Ozkaynak (3 out of 46 patents)

5. William K Jones (1 out of 5 patents)

6. Lawrence Berlowitz Tarrant (1 out of 4 patents)

7. Roy H Pang (1 out of 26 patents)

8. Ronald F Tucker (1 out of 8 patents)

4 patents: Sort by Forward Citations

1. 7078221 - Nucleic acid molecules encoding osteogenic proteins (2006-07-18),

2. 6077988 - Synthetic bone matrix (2000-06-20),

3. 6071708 - Morphogenic protein compositions of matter (2000-06-06),

4. 5958441 - Devices comprising chondrogenic protein and methods of inducing (1999-09-28),

Company Overview

Stryker Biotech is a division of Stryker Corporation specializing in innovative solutions for bone repair and regeneration. With a focus on developing cutting-edge technologies, Stryker Biotech aims to improve patient outcomes by offering advanced medical devices and therapies. The company's products are designed to address a variety of orthopedic conditions and are used by healthcare professionals worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#21 in Hopkinton, MA

#3,316 in Massachusetts

#60,704 in US

Hopkinton, MA, United States of America

Stryker Biotech

Forward Citations = 49

8 inventors:

Thangavel Kuberasampath (4 out of 67 patents)

Hermann Oppermann (3 out of 88 patents)

David C Rueger (3 out of 83 patents)

4. Engin Ozkaynak (3 out of 46 patents)

5. William K Jones (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Stryker Biotech. Retrieved from https://idiyas.com/company/stryker-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]